Description

BSE lists 3,71,000 new equity shares of Gujarat Terce Laboratories Limited issued on a preferential basis to promoters at Rs. 37.70 per share, effective for trading from February 25, 2026.

Summary

BSE has notified trading members that 3,71,000 new equity shares of Gujarat Terce Laboratories Limited (Scrip Code: 524314) have been listed and are permitted for trading on the Exchange effective Wednesday, February 25, 2026. These shares were issued on a preferential basis to promoters at an issue price of Rs. 37.70 per share (face value Rs. 10/- at a premium of Rs. 27.70).

Key Points

  • 3,71,000 equity shares of Rs. 10/- face value issued at a premium of Rs. 27.70 (issue price Rs. 37.70/-)
  • Shares issued to promoters on a preferential basis
  • New shares rank pari-passu with existing equity shares of the company
  • Distribution Numbers: 74,20,301 to 77,91,300
  • ISIN: INE499G01013
  • All 3,71,000 shares are subject to a lock-in period until June 16, 2027

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for newly allotted securities pursuant to a preferential issue approved by the company.

Compliance Requirements

  • Trading members are informed that the new securities are available for trading from February 25, 2026
  • The locked-in shares (74,20,301 to 77,91,300) are not available for trading until June 16, 2027
  • Members should update their records to reflect the new share distribution numbers and the applicable lock-in

Important Dates

  • Date of Allotment: December 16, 2025
  • Trading Effective From: February 25, 2026
  • Lock-in Expiry: June 16, 2027

Impact Assessment

The listing adds 3,71,000 shares to the tradable equity base of Gujarat Terce Laboratories Limited (Scrip Code: 524314). However, since all newly listed shares are under a lock-in until June 2027, there is no immediate increase in free-float. Market impact is minimal. The preferential allotment to promoters may slightly increase promoter shareholding percentage.

Impact Justification

Routine preferential allotment listing of a small tranche of shares to promoters; limited broader market impact, with shares under lock-in until mid-2027.